[HTML][HTML] The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
In 2019–2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent
of a several acute respiratory infection named COVID-19, which is causing a worldwide …
of a several acute respiratory infection named COVID-19, which is causing a worldwide …
[HTML][HTML] The pathogenesis and treatment of theCytokine Storm'in COVID-19
Q Ye, B Wang, J Mao - Journal of infection, 2020 - Elsevier
Cytokine storm is a general term applied to maladaptive cytokine release in response to
infection and other stimuli. The pathogenesis is complex but includes loss of regulatory …
infection and other stimuli. The pathogenesis is complex but includes loss of regulatory …
[HTML][HTML] Type I and type III interferons–induction, signaling, evasion, and application to combat COVID-19
A Park, A Iwasaki - Cell host & microbe, 2020 - cell.com
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Without approved antiviral therapeutics …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Without approved antiviral therapeutics …
[HTML][HTML] Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
Abstract Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in …
coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in …
[HTML][HTML] Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
B Liu, M Li, Z Zhou, X Guan, Y Xiang - Journal of autoimmunity, 2020 - Elsevier
The emergent outbreak of coronavirus disease 2019 (COVID-19) has caused a global
pandemic. Acute respiratory distress syndrome (ARDS) and multiorgan dysfunction are …
pandemic. Acute respiratory distress syndrome (ARDS) and multiorgan dysfunction are …
The many faces of the anti-COVID immune response
SA Vardhana, JD Wolchok - Journal of Experimental Medicine, 2020 - rupress.org
Disclosures: SA Vardhana reported personal fees from Immunai and personal fees from
ADC Therapeutics outside the submitted work; in addition, SA Vardhana had a patent to …
ADC Therapeutics outside the submitted work; in addition, SA Vardhana had a patent to …
Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies
Abstract Purpose Coronavirus disease 2019 (COVID-19) is an emerging disease that was
first reported in Wuhan city, the capital of Hubei province in China, and has subsequently …
first reported in Wuhan city, the capital of Hubei province in China, and has subsequently …
Lessons for COVID-19 immunity from other coronavirus infections
A Sariol, S Perlman - Immunity, 2020 - cell.com
A key goal to controlling coronavirus disease 2019 (COVID-19) is developing an effective
vaccine. Development of a vaccine requires knowledge of what constitutes a protective …
vaccine. Development of a vaccine requires knowledge of what constitutes a protective …
[HTML][HTML] Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
B Russell, C Moss, G George, A Santaolalla… - …, 2020 - ncbi.nlm.nih.gov
Background Cancer and transplant patients with COVID-19 have a higher risk of developing
severe and even fatal respiratory diseases, especially as they may be treated with immune …
severe and even fatal respiratory diseases, especially as they may be treated with immune …
[PDF][PDF] The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures
In December 2019, a viral pneumonia outbreak caused by a novel betacoronavirus, the
2019 novel coronavirus (2019-nCoV), began in Wuhan, China. We report the …
2019 novel coronavirus (2019-nCoV), began in Wuhan, China. We report the …